November 10th - November 14th, 2021 | Virtual & in-person in Washington, DC
Applied BioMath Presence
Poster: “A computational semi-mechanistic pharmacology model of ATG-101, a PD-L1/4-1BB bispecific antibody for treatment of solid tumors.”
Presented by: David Flowers, PhD, Principal Scientist at Applied BioMath
This work highlights our collaboration with Antengene.
Poster: "Dose selection for DuoBody®-PD-L1×4-1BB (GEN1046) using a semimechanistic pharmacokinetics/pharmacodynamics model that leverages preclinical and clinical data."